CELUW
Celularity Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+533.33%Price chart
Jun 15Jun 18Jun 24Jun 29Jul 2Jul 9Jul 14Jul 17
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
$50060.85
MomentumView details →
1D Return
+533.33%
YTD Return
−88.31%
RSI (14)
44.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
$50060.85
RSI (14)
44.2
MomentumView details →
1D Return
+533.33%
YTD Return
−88.31%
Similar companies
Latest newsMore news →
Celularity Inc. and MuseCell Innovations announced a U.S. manufacturing collaboration for the Dezawa MuseCell platform at Celularity's Florham Park, New Jersey facility.8d agoCelularity Inc. received a notification letter from Nasdaq on August 21, 2026, stating that the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to its failure to file its Quarterly Report on Form 10-Q for the period ended June 30, 2026, and its continued delinquency in filing the Form 10-Q for the period ended March 31, 2026.10d ago